IDEX Biometrics ASA
IDXAF
$0.89
$0.69345.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 254.00K | 209.00K | 269.00K | 573.00K | 841.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 254.00K | 209.00K | 269.00K | 573.00K | 841.00K |
| Cost of Revenue | 612.00K | 1.34M | 1.36M | 1.53M | 1.68M |
| Gross Profit | -358.00K | -1.13M | -1.09M | -960.00K | -843.00K |
| SG&A Expenses | 2.65M | 3.34M | 4.69M | 6.54M | 8.80M |
| Depreciation & Amortization | 479.00K | 1.82M | 1.31M | 2.27M | 2.52M |
| Other Operating Expenses | 5.28M | 6.51M | 6.73M | 6.88M | 7.29M |
| Total Operating Expenses | 10.39M | 14.27M | 16.39M | 19.63M | 22.74M |
| Operating Income | -10.13M | -14.06M | -16.13M | -19.06M | -21.90M |
| Income Before Tax | -10.04M | -11.09M | -8.74M | -13.29M | -14.57M |
| Income Tax Expenses | -41.00K | -163.00K | -163.00K | -118.00K | -120.00K |
| Earnings from Continuing Operations | -10.00 | -10.93 | -8.57 | -13.17 | -14.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.00M | -10.93M | -8.57M | -13.17M | -14.45M |
| EBIT | -10.13M | -14.06M | -16.13M | -19.06M | -21.90M |
| EBITDA | -9.41M | -11.91M | -13.88M | -15.85M | -18.52M |
| EPS Basic | -0.65 | -1.30 | -0.84 | -3.06 | -4.50 |
| Normalized Basic EPS | -0.07 | -0.74 | -0.46 | -1.84 | -3.04 |
| EPS Diluted | -0.65 | -1.30 | -0.84 | -3.06 | -4.57 |
| Normalized Diluted EPS | -0.07 | -0.74 | -0.46 | -1.84 | -3.04 |
| Average Basic Shares Outstanding | 127.59M | 85.59M | 46.61M | 19.64M | 14.12M |
| Average Diluted Shares Outstanding | 127.59M | 85.59M | 46.63M | 19.66M | 14.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |